Table of Contents
Overview
Definition of Cardiology
Cardiology is defined as the branch of medicine that focuses on the study and treatment of disorders related to the heart and blood vessels. This medical specialty encompasses the diagnosis and management of various cardiovascular conditions, including congenital heart defects, coronary artery disease, heart failure, valvular heart disease, and electrophysiology.[3.1] The field of cardiology is primarily concerned with non-surgical interventions, as cardiologists specialize in the ongoing care of patients with cardiovascular diseases, conducting assessments of heart function and overseeing therapeutic measures, including pharmacological treatments.[5.1] The cardiovascular system, which cardiology addresses, comprises the heart, veins, arteries, and capillaries, organized into two main circulatory systems: the systemic and pulmonary circulatory systems.[6.1]Importance of Cardiovascular Health
Cardiovascular health is critical for overall well-being, as heart disease remains a leading cause of morbidity and mortality worldwide. A common misconception is that heart disease predominantly affects men; however, women are also significantly impacted, often developing cardiovascular disease later in life but with equally serious consequences.[8.1] This misunderstanding can lead to inadequate awareness and prevention efforts among women, emphasizing the need for comprehensive education on heart health for all genders. Misbeliefs about heart disease can be dangerous, as they may prevent individuals from recognizing their risk factors and taking necessary preventive measures. For instance, myths such as "it's okay to have high blood pressure when you are old" or "controlled diabetes won't cause heart disease" can lead to complacency regarding health management.[9.1] Furthermore, the belief that lifestyle changes are unnecessary if one is on medication can undermine the importance of holistic health approaches.[10.1] Effective patient education strategies are essential in combating these misconceptions and promoting cardiovascular health. Programs like the CHOICE initiative, which provides disease-specific information through various formats, have shown promise in enhancing health literacy among patients.[11.1] Structured educational programs integrated into care organizations can significantly improve self-care skills and quality of life for patients, particularly those recovering from acute coronary syndrome.[13.1] Moreover, lifestyle changes are a proven method for preventing heart disease, yet many individuals struggle to implement these changes without support. Primary care providers play a crucial role in facilitating access to counseling and resources that encourage healthy behaviors.[14.1] Cognitive-based behavior change strategies, which focus on altering patients' perceptions of their health and behaviors, have been identified as effective in promoting lasting lifestyle modifications.[15.1] Despite the clear benefits of healthy lifestyle choices, engagement in such behaviors remains suboptimal among the general population.[16.1] Family physicians can utilize evidence-based interventions, such as goal setting and visualization techniques, to assist patients in making significant health behavior changes.[17.1] By addressing misconceptions and providing robust educational support, healthcare providers can foster a more informed and proactive approach to cardiovascular health.History
Development of Cardiology as a Medical Specialty
The development of cardiology as a medical specialty has evolved significantly over centuries, marked by key milestones and contributions from various cultures and individuals. The earliest understandings of heart health can be traced back to ancient civilizations, where the heart was often regarded as the seat of life and emotion. For instance, ancient Egyptians believed the heart was central to thought and wisdom, preserving it during mummification while discarding the brain.[66.1] Similarly, ancient Chinese texts, such as the Huangdi Neijing, emphasized the heart's role in maintaining health and balance, referring to it as a "kind and benevolent emperor".[68.1] In the realm of ancient Indian medicine, Ayurveda provided a holistic approach to health, including heart care, through herbal remedies and lifestyle practices.[69.1] The Greeks, particularly through the works of Hippocrates and Galen, made significant strides in understanding the heart's anatomy and function, laying the groundwork for clinical medicine.[69.1] Galen's treatises reaffirmed the heart's central role in the body, contributing to the early scientific discourse surrounding cardiovascular health.[67.1] The formal establishment of cardiology as a distinct medical specialty began in the early 20th century. In 1934, American cardiologist Bishop, with the assistance of Russel Burton Opitz, organized the New York Cardiological Society, which marked a pivotal moment in the professionalization of cardiology.[52.1] This initiative was part of a broader movement to elevate the standards of American cardiology to match those of Europe, reflecting a commitment to advancing the field.[52.1] Throughout the 20th century, significant advancements were made in diagnostic techniques, notably cardiac catheterization, which became a cornerstone for assessing cardiac function and diagnosing heart diseases.[55.1] Despite these advancements, cardiovascular disease (CVD) remains the leading cause of death globally, underscoring the ongoing challenges faced by the specialty.[56.1] In recent years, the field has witnessed a surge in scientific output and technological innovations, particularly with the integration of artificial intelligence and telemedicine into cardiovascular care.[57.1] These advancements are transforming diagnostic and treatment methodologies, highlighting the continuous evolution of cardiology as a vital medical specialty.[60.1]Milestones in Cardiac Care
The evolution of cardiac care has been marked by several significant milestones that have transformed the diagnosis and treatment of cardiovascular diseases. One of the earliest milestones was the description of blood circulation by William Harvey in 1628, which laid the groundwork for understanding cardiovascular physiology.[76.1] This foundational knowledge was further advanced in 1929 when Dr. Werner Forssmann performed the first documented human cardiac catheterization in Eberswald, Germany, a pioneering act that would eventually earn him the Nobel Prize in Medicine in 1956.[78.1] In the early 1940s, André Cournand and Dickinson Richards utilized cardiac catheterization as a diagnostic tool, marking a significant advancement in the ability to measure cardiac output and assess heart function.[79.1] This innovation was complemented by Mason Sones' introduction of selective coronary angiography in the early 1960s, which allowed for detailed visualization of coronary arteries and significantly improved diagnostic capabilities in cardiology.[79.1] The development of cardiac imaging technologies has also played a crucial role in advancing cardiac care. Recent advancements in modalities such as cardiac magnetic resonance imaging (MRI) and computed tomography (CT) have enhanced the ability to diagnose and treat cardiovascular diseases. These technologies have become more accessible due to improvements in hardware and software, facilitating coronary artery calcium scoring and coronary CT angiography.[63.1] Furthermore, the integration of data-driven and patient-focused solutions in cardiac imaging reflects a broader trend in modern medicine, promising continued expansion of these capabilities.[62.1]Recent Advancements
Technological Innovations in Cardiology
Recent advancements in cardiology have been significantly influenced by technological innovations, particularly in the realms of genetic research and artificial intelligence (AI). The CRISPR-Cas system has emerged as a revolutionary tool in genetic research, enabling highly precise gene editing that has advanced the field of cardiovascular science. This technology has facilitated the development of realistic disease models for various cardiac disorders, including dilated cardiomyopathy (DCM) and hypertrophic cardiomyopathy (HCM), which are critical given the global prevalence of heart diseases.[107.1] The CRISPR-Cas9 system specifically allows for efficient double-stranded DNA cleavage, which is essential for genome editing aimed at correcting inherited genetic mutations that cause diseases, such as congenital heart disease (CHD). These mutations often manifest as base substitutions, deletions, or insertions, leading to diverse cardiac conditions.[108.1] Notably, a mutation in the MYBPC3 gene accounts for 40% of genetic defects causing hypertrophic cardiomyopathy, and recent studies have successfully corrected such mutations using CRISPR technology.[109.1] Although current studies utilizing CRISPR-Cas9 technology are primarily experimental and limited to animal models, the promising results suggest that this technology could soon be integrated into clinical medicine for diagnosing and treating cardiovascular diseases.[110.1] In addition to genetic innovations, AI is transforming cardiology through enhanced early detection and personalized treatment strategies. AI systems are capable of analyzing complex lifestyle data and medical images, allowing for earlier and more accurate detection of heart disease compared to traditional methods. For instance, AI can detect heart disease 40% faster, significantly reducing diagnostic errors and ensuring timely interventions.[114.1] Furthermore, AI-driven decision support systems are being developed to unveil patterns and predict myocardial ischemia, which can lead to improved patient outcomes and more effective healthcare strategies.[113.1] The integration of AI in cardiology is expected to evolve significantly over the next five to ten years, with advancements likely to focus on refining algorithms for risk prediction and therapeutic decision-making. This evolution is crucial, as traditional data analysis methods often fall short in managing the multidimensional data associated with cardiovascular diseases.[115.1] Overall, the combination of CRISPR technology and AI represents a paradigm shift in cardiology, promising to enhance both the understanding and treatment of heart diseases.Breakthrough Treatments and Therapies
Recent advancements in cardiology have led to several breakthrough treatments and therapies that promise to enhance patient outcomes significantly. One notable development is the emergence of anti-obesity medications, particularly semaglutide and tirzepatide, which have demonstrated substantial cardiovascular benefits. These medications have been shown to reduce major cardiovascular events by up to 20% in patients with existing heart conditions, contributing to an impressive 84% overall five-year survival rate among carefully selected patients.[95.1] Clinical trials have highlighted the efficacy of these drugs in managing heart failure, particularly in patients with heart failure with preserved ejection fraction (HFpEF) and obesity.[104.1] In addition to pharmacological advancements, the integration of artificial intelligence (AI) in cardiology is revolutionizing early detection systems, allowing for more timely and accurate diagnoses.[97.1] Furthermore, innovative gene therapies, including CRISPR technology, are being explored to target specific heart diseases, enhancing the potential for personalized treatment approaches.[125.1] The American Heart Association (AHA) has also noted significant progress in cardiovascular research, emphasizing the rising burden of cardiovascular disease (CVD) and the need for continued innovation in treatment strategies.[96.1] This includes advancements in the management of lipid disorders and the development of new antihypertensive agents, which are currently undergoing clinical trials.[98.1]Risk Factors For Cardiovascular Diseases
Modifiable Risk Factors
Modifiable risk factors for cardiovascular diseases (CVD) are those that individuals can change or manage to reduce their risk of developing heart-related conditions. Key modifiable risk factors include lifestyle choices and health conditions that significantly influence cardiovascular health. One of the primary modifiable risk factors is high blood pressure, which is a major contributor to heart disease. It can be managed through lifestyle changes such as diet, exercise, and medication if necessary.[144.1] Additionally, obesity is another critical risk factor, as it can lead to high blood pressure and diabetes, both of which further increase the risk of heart disease.[144.1] Cigarette smoking is also a significant modifiable risk factor for CVD. Smoking not only damages blood vessels but also contributes to the buildup of plaque in arteries, leading to a higher likelihood of heart attacks.[142.1] Furthermore, excessive alcohol consumption can raise blood pressure levels and increase the risk of heart disease, making moderation essential.[144.1] Diet plays a crucial role in managing cardiovascular health. Adopting a heart-healthy diet, such as the Mediterranean or DASH diet, can significantly lower the risk of cardiovascular diseases. These diets emphasize the consumption of fruits, vegetables, whole grains, and healthy fats while reducing intake of saturated fats and sugars.[154.1] Studies have shown that the Mediterranean diet is associated with a 37% relative reduction in the risk of major cardiovascular events [151.1], while the DASH diet has been linked to decreased incidence of cardiovascular disease and improved blood pressure.[153.1]Non-Modifiable Risk Factors
Non-modifiable risk factors for cardiovascular diseases (CVD) include age, sex, and genetic predispositions, which cannot be altered through lifestyle changes. Age is a significant factor, as approximately 80% of individuals who die from cardiovascular disease are aged 65 years or older, indicating that the risk of developing heart disease increases with age.[180.1] Additionally, sex plays a role in CVD risk, with differences observed between males and females in terms of susceptibility and outcomes.[180.1] Genetic factors also contribute to non-modifiable risks. Research has identified several important genes, particularly those related to lipid metabolism, where rare genetic variations are associated with increased CVD risk. Furthermore, a polygenic risk score that incorporates common genetic variations has been shown to effectively predict cardiovascular risk in the general population.[178.1] An international research collaboration, including the CARDioGRAM and the Coronary Artery Disease Genetics Consortia, has confirmed ten previously identified genetic markers linked to heart disease and discovered 13 new markers that further elevate the risk.[177.1] While these non-modifiable factors are critical to understanding an individual's risk profile, it is essential for patients to recognize that they cannot change these aspects of their health. However, awareness of these factors can empower individuals to focus on modifiable risk factors, such as managing diabetes, obesity, and lifestyle choices, which can significantly influence overall cardiovascular health.[181.1]In this section:
Therapeutic Strategies
Pharmacological Treatments
Pharmacological treatments for cardiovascular diseases (CVDs) have evolved significantly, with a focus on addressing unmet medical needs and improving patient outcomes. Traditional therapies have proven effective; however, they have not sufficiently curbed the rising prevalence of CVDs, which are exacerbated by aging populations and lifestyle factors. Consequently, there is a pressing need for innovative therapeutic strategies that can enhance the management of these conditions.[197.1] Recent advancements in pharmacology have led to the development of novel drug therapies, including proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors and sodium-glucose cotransporter-2 (SGLT2) inhibitors, which represent promising areas of research in cardiovascular drug therapies.[200.1] The U.S. Food and Drug Administration (FDA) has approved a total of 28 new molecular entities (NMEs) for the treatment of CVDs from 2011 to 2023, with approximately 25% of these medications targeting various vascular disorders.[196.1] Among these, vutrisiran (brand name Amvuttra) has been approved specifically for adults with transthyretin amyloid cardiomyopathy (ATTR-CM), highlighting the ongoing innovation in pharmacological treatments.[198.1] Emerging therapies also encompass biological treatments, advanced medical devices, and personalized medicine approaches. Personalized medicine, which tailors treatment based on individual patient characteristics, has the potential to improve clinical outcomes by moving away from a one-size-fits-all model.[216.1] This approach is supported by advancements in pharmacogenomics, which optimize drug therapy based on genetic information, thereby enhancing the efficacy and safety of treatments.[217.1] The integration of these emerging therapeutic strategies into cardiovascular care is expected to transform CVD management, paving the way for more effective and accessible treatment options.[185.1]In this section:
Patient Management
Preventive Cardiology
Preventive cardiology has evolved significantly with the introduction of innovative management strategies such as Principal Care Management (PCM). PCM is particularly beneficial for patients with a single high-risk chronic condition, offering specialized and intensive care management tailored to individual needs. This approach is especially effective in managing complex cardiovascular diseases, including hypertension, which is a prevalent issue in cardiology care.[232.1] The implementation of PCM has transformed the management of chronic cardiovascular conditions by focusing on patients who require extensive management due to the severity of their conditions. These patients typically have chronic issues expected to last at least three months and pose a substantial risk of hospitalization or health deterioration.[235.1] Evidence suggests that chronic care management, including PCM, can significantly reduce mortality rates, with a meta-analysis indicating a mean reduction of 18%.[234.1] In addition to PCM, patient engagement and education are critical components of preventive cardiology. Effective patient education empowers individuals with the knowledge and skills necessary for self-management, which is essential for improving health outcomes in chronic conditions.[240.1] Strategies such as shared decision-making (SDM) enhance patient-provider communication and align treatment plans with patients' values and preferences, thereby fostering a collaborative approach to care.[238.1] Furthermore, the role of healthcare professionals, particularly nurses, is pivotal in promoting patient engagement and adherence to treatment plans. Studies indicate that participation in cardiac rehabilitation programs is often low, highlighting the need for improved support and motivation strategies.[237.1] By integrating these elements into treatment plans, healthcare providers can enhance patient satisfaction and overall health outcomes in cardiology.[236.1]Role of Health Technology in Patient Monitoring
The integration of health technology in patient monitoring has become increasingly vital in the management of cardiovascular diseases (CVD). Digital health interventions (DHIs), which include teleconsultations, smartphone applications, wearables, remote monitoring, and predictive analytics, have demonstrated significant potential in influencing patient behaviors for both the primary and secondary prevention of coronary artery disease and the management of heart failure (HF).[246.1] As HF is the most common hospital discharge diagnosis among older adults in the United States, the application of these technologies is particularly crucial, especially considering that one-fifth of HF patients are readmitted within 30 days of discharge.[246.1] Telecardiology plays a pivotal role in the remote diagnosis and management of acute cardiac events, such as myocardial infarctions, by facilitating real-time data transmission and collaboration between primary care providers and cardiologists. This capability enhances patient health outcomes through improved monitoring and timely interventions.[247.1] Furthermore, telemedicine has been shown to effectively replace in-person follow-up visits, yielding comparable outcomes in cardiovascular disease management while potentially reducing follow-up time and enabling earlier detection of adverse events.[248.1] The integration of advanced patient engagement technologies is not merely a trend but a necessity for improving care delivery and patient outcomes. Platforms like Veradigm FollowMyHealth have reported a 20% increase in medication adherence among users, highlighting the effectiveness of tailored treatment plans and telehealth features in enhancing patient engagement.[252.1] As we approach 2025, the role of telehealth is expected to expand further, becoming a cornerstone of healthcare delivery and driving improvements in patient outcomes and healthcare efficiency.[255.1] The shift towards patient-centered care, facilitated by these technologies, is anticipated to enhance patient satisfaction and overall health outcomes.[254.1] In the context of heart failure management, the Information Technology Management (ITM) system exemplifies the integration of digital tools designed to optimize patient and caregiver engagement. This comprehensive framework aims to transform patient care through innovative technology, underscoring the importance of digital health technologies in enhancing engagement and adherence to treatment plans.[256.1] Overall, the convergence of digital health technologies and interventional cardiology is poised to redefine patient management in cardiology, making it more efficient and effective.In this section:
Future Directions
Emerging Research and Innovations
Emerging research and innovations in cardiology are poised to significantly reshape the landscape of cardiovascular disease prevention and treatment. A key focus is on primordial prevention, which emphasizes the early identification and prevention of cardiovascular risk factors, rather than waiting for their development. This proactive approach aims to mitigate the onset of conditions such as high blood pressure, high cholesterol, and diabetes from a young age.[269.1] The integration of precision medicine into cardiology represents another transformative advancement. This approach tailors treatment based on individual patient characteristics, utilizing advanced “omics” data to identify specific subgroups with distinct disease mechanisms. Such personalization is expected to enhance the effectiveness of antihypertensive treatments and improve overall patient outcomes.[270.1] Furthermore, the American Heart Association has identified critical measures that, if effectively managed, could substantially reduce the risk of heart disease and stroke, highlighting the importance of addressing cardiovascular risk factors through innovative strategies.[271.1] Recent advancements in RNA-based therapies also hold promise for the treatment of various cardiovascular conditions. The rapid development of RNA-based vaccines during the COVID-19 pandemic has catalyzed interest in RNA therapeutics for cardiac diseases, including heart failure and genetic cardiomyopathies. These therapies are still in the early stages but show encouraging results, particularly in managing hypercholesterolemia and myocardial infarction.[279.1] As research progresses, RNA-based treatments are expected to become more prevalent, offering new avenues for intervention in cardiovascular disease.[281.1] Moreover, the integration of genomic data into clinical practice is anticipated to enhance the identification of at-risk patients and facilitate personalized treatment plans. This evolution towards precision cardiology involves the incorporation of multimodal data, including genetic information, to inform diagnoses and tailor therapies.[283.1] Ongoing research is focused on refining risk prediction algorithms and exploring innovative applications, such as induced pluripotent stem cells for cardiac tissue regeneration.[286.1] In addition to these advancements, mobile health technologies, including wearable devices, are gaining traction in adult populations, although their application in pediatric cardiology remains limited. The potential for these technologies to enhance early intervention strategies in children with specific cardiovascular pathologies is an area of ongoing exploration.[287.1]References
[3] Cardiology - Wikipedia — Cardiology (from Ancient Greek καρδίᾱ (kardiā) ' heart ' and -λογία () ' study ') is the study of the heart.Cardiology is a branch of medicine that deals with disorders of the heart and the cardiovascular system.The field includes medical diagnosis and treatment of congenital heart defects, coronary artery disease, heart failure, valvular heart disease, and electrophysiology.
[5] Cardiology | Heart Disease, Diagnosis & Treatment | Britannica — cardiology, medical specialty dealing with the diagnosis and treatment of diseases and abnormalities involving the heart and blood vessels.Cardiology is a medical, not surgical, discipline.Cardiologists provide the continuing care of patients with cardiovascular disease, performing basic studies of heart function and supervising all aspects of therapy, including the administration of drugs to
[6] Cardiovascular system: Function, organs, diseases, and more — The cardiovascular system consists of the heart, veins, arteries, and capillaries. These components make up two circulatory systems: the systemic and pulmonary circulatory systems.
[8] Common Myths About Heart Disease - Go Red for Women — Common Myths About Heart Disease "It's a man's disease." "But I'm too young." "Breast cancer is the real threat." If you've heard or said any of this before about heart disease, you're not alone. The real fact is, relying on these false assumptions can cost you your life. It's time to set the record straight and start
[9] 10 myths about heart disease - Harvard Health — Believing outdated ideas about heart disease and what causes it can be dangerous. Ten myths that persist include the need for people with heart disease to take it easy; taking a cholesterol-lowering drug means you can eat anything you want; it's okay to have high blood pressure when you are old; controlled diabetes won't cause heart disease; supplements of antioxidants can lower the risk
[10] Top 10 Myths About Cardiovascular Disease - American Heart Association — How much do you really know about your heart health? If left untreated, high blood pressure can cause heart attack, stroke, kidney damage and other serious health problems. But even when blood sugar levels are under control, you’re still at increased risk for heart disease and stroke. Create an action plan to keep your heart healthy by tackling these to-dos: get active; control cholesterol; eat better; manage blood pressure; maintain a healthy weight; control blood sugar; manage stress; get quality sleep and stop smoking. Family History, Heart Disease and Stroke Family History, Heart Disease and Stroke *All health/medical information on this website has been reviewed and approved by the American Heart Association, based on scientific research and American Heart Association guidelines.
[11] Patient Education Strategies for Coronary Heart Disease in a Cardiac ... — Patient education strategies such as CHOICE program, providing disease-specific information in the form of booklet and videos, curriculum-based education on coronary heart disease, the cardiac college which is part of an E-health university to improve the health literacy of patients, inpatient psychoeducation, audience response system, and LC
[13] Heart Disease, Now What? Improving Quality of Life through Education — Conclusions: According to the findings of the study, a systematized and structured educational program, integrated into the care organization and based on transition processes, is effective in developing self-care skills and improves the quality of life in patients after acute coronary syndrome. These educational programs can represent an important strategy in the fight against heart disease because they enable the development of self-care skills necessary for patients to reach their potential and quality of life (QoL) . Authors also observed that all patients of the experimental group obtained results equal to 60 points (maximum value of the therapeutic self-care assessment scale).
[14] How doctors can help their patients make heart-healthy lifestyle changes — Lifestyle change is a powerful, proven way for a person to prevent heart disease. But to make healthy changes stick, people often need a little help. Primary care doctors could offer crucial assistance in connecting patients with counseling that's been shown to make a difference.
[15] PDF — Helping patients make a lifestyle change is a challenge for health care providers with limited time allocated during typical outpatient clinic visits. Cognitive-based behavior change strategies seem to be key to successful change—these strategies focus on changing how an individual thinks about themselves, their behaviors and life circumstances.
[16] Strategies for Promotion of a Healthy Lifestyle in Clinical Settings ... — Engagement in healthy lifestyle behaviors is suboptimal. The vast majority of the US population does not meet current recommendations. A healthy lifestyle is defined by consuming a healthy dietary pattern, engaging in regular physical activity, avoiding exposure to tobacco products, habitually attaining adequate amounts of sleep, and managing stress levels. For all these health behaviors there
[17] Encouraging Health Behavior Change: Eight Evidence-Based Strategies - AAFP — Effectively encouraging patients to change their health behavior is a critical skill for primary care physicians. Family physicians regularly encounter patients who engage in unhealthy behaviors; evidence-based interventions may help patients succeed in making lasting changes. This article will describe brief, evidence-based techniques that family physicians can use to help patients make selected health behavior changes. Family physicians can use brief, evidence-based techniques to encourage patients to change their unhealthy behaviors. Goal setting is a key intervention for patients looking to make behavioral changes.3 Helping patients visualize what they need to do to reach their goals may make it more likely that they will succeed.
[52] A History of the Development of Cardiology as a Medical Specialty — There is a long list of other contributions less well known, but they should be at least mentioned to support the thesis of "no boundaries." Therefore I shall present a brief history of the development of clinical cardiology as a medical specialty as seen from the view-point of an American cardiologist. Eight years later, in 1934, with the help and counsel of Russel Burton Opitz, a practicing cardiologist and professor of physiology at a medical school, Bishop was able to convene a group and organize the New York Cardiological Society. There were a number of discussion meetings, but Groedel kept pushing; he had a clear notion of the national College and what it could do to make the American specialty of cardiology come up to the European standard.
[55] Cardiology: the past, the present, and the future | JACC — They recorded intracardiac pressures and cardiac output in normal subjects and in patients with many forms of congenital and acquired heart disease. These investigators established cardiac catheterization as the basis for defining normal and disordered function of the cardiac pump and as a premier diagnostic technique in cardiology.
[56] Cardiology: A Century of Progress | Circulation - AHA/ASA Journals — Our predecessors, despite a lack of data and experience, clearly established cardiology as an important medical specialty; we stand on the shoulders of giants. Although cardiology has progressed dramatically, cardiovascular disease remains the most common cause of death worldwide, and much remains to be accomplished.
[57] Technological Advances in the Diagnosis of Cardiovascular Disease: A ... — An increase in scientific output since 2018 was observed, reflecting a growing interest in the technologies available for the treatment of cardiovascular diseases, with terms such as “telemedicine”, “artificial intelligence”, “image analysis”, and “cardiovascular disease” standing out as some of the most commonly used terms in reference to CVDs. Significant trends were identified, such as the use of artificial intelligence in precision medicine and machine learning algorithms to analyse data and predict cardiovascular risk, as well as advances in image analysis and 3D printing.
[60] Transforming Cardiovascular Care With Artificial Intelligence: From ... — Artificial intelligence (AI) has the potential to transform every facet of cardiovascular practice and research. The exponential rise in technology powered by AI is defining new frontiers in cardiovascular care, with innovations that span novel diagnostic modalities, new digital native biomarkers of disease, and high-performing tools evaluating care quality and prognosticating clinical outcomes.
[62] Cardiac Imaging Technology in Diagnostics | Open Medscience — In many respects, recent advances in heart imaging mirror the broader push in modern medicine towards integrated, data-driven, and patient-focused solutions. As researchers and clinicians work together to refine existing methods and pioneer new approaches, the capabilities of cardiac imaging will continue to expand, holding the promise of
[63] Recent Advances in Cardiac Magnetic Resonance Imaging — Although several limitations, including the high cost and time-consuming process, have limited the widespread clinical use of CMR imaging so far, recent advances in software and hardware technologies have made the future more promising. Keywords: Cardiology, Magnetic resonance imaging, Cardiac magnetic resonance. INTRODUCTION
[66] History of Heart Health: From Ancient Remedies to Modern Medicine — The history of heart health dates back to ancient civilizations, where the heart was often seen as the seat of life, emotion, and even the soul. Ancient Egyptians believed that the heart was the center of thought and wisdom. In fact, during mummification, the heart was often preserved while the brain was discarded. This belief in the heart as a
[67] A HISTORY OF THE HEART - Stanford University — A HISTORY OF THE HEART . Introduction. Ancient physicians, such as Galen, focused a great deal of attention on the heart and its central role in the body. In his treatise On the Usefulness of the Parts of the Body, Galen reaffirmed common ideas about the heart as the source of the body's innate heat and as the organ most closely related to the
[68] The Ancient Heart: What the Heart Meant to Our Ancestors — Xin, the ancient Chinese word for heart, was also translated "heart-mind." The heart ruled the body. The heart ruled the body. As stated in Huangdi Neijing or The Yellow Emperor's Classic of Medicine from 2600 BCE, when the body is healthy and balanced, the heart is a "kind and benevolent emperor" ( 2 ).
[69] The evolution of ancient healing practices: From shamanism to ... — Similarly, in ancient India, Ayurveda emerged as a holistic system of medicine, emphasizing the balance of mind, body, and spirit. Ayurvedic texts, such as the Charaka Samhita and the Sushruta Samhita, detailed diagnosis, treatment, and prevention principles, including herbal remedies, dietary guidelines, and yoga practices. The ancient Greeks, particularly during the Classical period, made significant contributions to the development of medical science through the work of physicians like Hippocrates and Galen. Hippocratic medicine, named after the renowned physician Hippocrates, emphasized rational observation, naturalistic explanations for disease, and ethical principles guiding medical practice. The Hippocratic Corpus, a collection of texts attributed to Hippocrates and his followers, laid the foundation for clinical medicine, advocating for the systematic study of symptoms, prognosis, and treatment outcomes. Galen, a prominent physician of the Roman Empire, further expanded upon Hippocratic teachings, contributing to advancements in anatomy, physiology, and pharmacology. The legacy of ancient healing practices extends far beyond historical curiosity, influencing contemporary approaches to healthcare and wellness.
[76] The history of cardiac catheterization - PubMed — The evolution of cardiac catheterization has occurred over at least four centuries. One of the first major steps was the description of the circulation of the blood by William Harvey in 1628. The next milestone was the measurement of arterial pressure by Stephen Hales, one century later. However, th …
[78] History of heart catheterization - Siemens Healthineers — Today, cardiac catheterization is a common practice and can be used not only to diagnose a multitude of cardiological diseases but also to treat them directly - and these capabilities are founded upon Werner Forssmann's daring self-experiment. In 1956, Forssmann received the Nobel Prize in Medicine for the first cardiac catheter examination.
[79] The history of cardiac catheterization - PubMed — The history of cardiac catheterization - PubMed Search: Search Your saved search Name of saved search: Search in PubMed Add to Search The history of cardiac catheterization The history of cardiac catheterization Search in PubMed Add to Search Human cardiac catheterization developed during the 20th century. Diagnostic cardiac catheterization was introduced by André Cournand and Dickinson Richards in the early 1940s, and selective coronary angiography was described by Mason Sones in the early 1960s. [Historic perspective of cardiac catheterization]. Add to Search Add to Search Cardiac Catheterization / history* Add to Search Add to Search Add to Search Add to Search Add to Search Add to Search Add to Search Add to Search Add to Search Add to Search
[95] Breakthrough Heart Treatments of 2025- A New Era in Cardiology — Home > Blog > Cardiology > Breakthrough Heart Treatments of 2025- A New Era in Cardiology Anti-obesity medications such as semaglutide and tirzepatide have shown impressive results, reducing major cardiovascular events by up to 20% in patients with existing heart conditions. Hence, these criteria have improved treatment outcomes, as demonstrated by an 84% overall 5-year survival rate among carefully selected patients. Key breakthroughs include anti-obesity drugs showing significant cardiovascular benefits, AI-powered early detection systems, CRISPR gene therapy targeting heart disease, and new treatments for cardiac amyloidosis. Clinical trials have shown promising results, with a single dose achieving significant reductions in TTR protein levels and improvements in patient mobility and cardiac function. Breakthrough Heart Treatments of 2025- A New Era in Cardiology March 3, 2025
[96] AHA Names 7 Cardiovascular Research Breakthroughs in 2024 — The American Heart Association (AHA) has released its annual review of major scientific advances in cardiovascular research, citing significant progress in 2024 . We summarise a few of the key advances they name in their article, with essential reading referenced: 1.Rising cardiovascular disease burdenCardiovascular disease (CVD) prevalence is expected to rise from 11.3% to 15% of the U.S
[97] 2024 look-ahead: Cardiology trends and breakthroughs - MDLinx — A number of advances are expected this year in the field of cardiology, from management of lipid disorders, to new challenges in obesity management, to cardio-focused advancements in AI.
[98] Revolutionary advances in the future of cardiology - Mayo Clinic — Revolutionary advances in the future of cardiology - Mayo Clinic Care at Mayo Clinic About Mayo Clinic Mayo Clinic Laboratories Research & Education at Mayo Clinic Research at Mayo Clinic Mayo Clinic School of Graduate Medical Education Mayo Clinic School of Health Sciences Mayo Clinic School of Continuous Professional Development We can also use RNA technology to develop targeted therapeutic agents for hypertension, and several new antihypertensive agents are currently undergoing clinical trials. Refer a patient to Mayo Clinic. About Mayo Clinic Mayo Clinic Privacy Policy Mayo Clinic and our partners use technologies such as cookies to collect information from your browser to deliver relevant advertising on our site, in emails and across the Internet, personalize content and perform site analytics.
[104] Advances in the management of obesity and heart failure: latest ... — Antiobesity medications such as semaglutide and tirzepatide may represent important treatment options for patients with obesity-related HFpEF. Additional evidence suggests that certain other HF medications may have increased efficacy in patients with obesity. ... Purpose of review: Obesity is an important risk factor for heart failure with
[107] Recent development in CRISPR-Cas systems for cardiac disease — The focus here is on the use of CRISPR-Cas technologies in investigating cardiac disorders, a critical area given the global prevalence of heart diseases. 2 Through precise gene editing, CRISPR-Cas has facilitated the development of realistic disease models, such as those for dilated cardiomyopathy (DCM), hypertrophic cardiomyopathy (HCM), and
[108] Application of CRISPR-Cas9 gene editing for congenital heart disease — The CRISPR-Cas9 system facilitates efficient double-stranded DNA cleavage that has been recently adopted for genome editing to create or correct inherited genetic mutations causing disease. Congenital heart disease (CHD) is generally caused by genetic mutations such as base substitutions, deletions, and insertions, which result in diverse
[109] CRISPR-Cas9 Applications in Cardiovascular Disease — A mutation in the MYBPC3 gene as such accounts for 40% of genetic defects causing hypertrophic cardiomyopathy, characterized by ventricular hypertrophy and abnormal myocardial relaxation leading to arrhythmias and diastolic heart failure. 11, 12 Ma et al successfully corrected a heterozygous four base pair deletion in the MYBCP3 gene using
[110] The Use of CRISPR-Cas9 Genetic Technology in Cardiovascular Disease: A ... — We focused on summarizing recent studies using CRISPR-Cas9 technology in diagnosing and treating cardiovascular disease. These studies are primarily experimental and limited to animal models. However, their results are promising enough to anticipate that this technology will undoubtedly be available in clinical medicine in the coming years.
[113] AI-Driven Decision Support for Early Detection of Cardiac Events ... — AI-Driven Decision Support for Early Detection of Cardiac Events: Unveiling Patterns and Predicting Myocardial Ischemia. ... leading to improved patient outcomes and more effective healthcare strategies . ... Gaffar S., Chang A.C. A primer on artificial intelligence for the paediatric cardiologist. Cardiol. Young. 2020;30:934-945. doi: 10.
[114] AI in Cardiology: Faster Diagnoses, Better Results - Matellio Inc — Diagnose Faster, Treat Sooner . AI detects heart disease 40% faster than traditional methods, reducing diagnostic errors and ensuring early intervention.In fact, AI for cardiology diagnostics improves ECG and imaging analysis, cutting report turnaround time by up to 50%!. Faster diagnoses = more patients treated, higher revenue per day.
[115] Early Diagnosis of Cardiovascular Diseases in the Era of Artificial ... — Early detection of cardiovascular events may lower the occurrence of acute myocardial infarction and reduce death rates in people with CVDs. Traditional data analysis is inadequate for managing multidimensional data related to the risk prediction of CVDs, heart attacks, medical image interpretations, therapeutic decision-making, and disease prognosis due to the complex pathological mechanisms and multiple factors involved. The first study demonstrating the efficacy of ML modeling on whole genome transcriptomic data for clinical cardiomyopathy diagnosis was carried out by Alimadadi et al. AI has the ability to assess data from many imaging modalities and complex medical diagnoses in order to develop algorithms that may enhance prenatal diagnosis, adult disease therapy, and outcome prediction [130-134]. 57.Current state of artificial intelligence-based algorithms for hospital admission prediction in patients with heart failure: a scoping review.
[125] Gene Therapy for the Heart Lessons Learned and Future Perspectives — We also emphasize a few areas of cardiac gene therapy development that hold great promise for the future. In particular, the transition from gene addition studies using protein-coding cDNAs to the modulation of gene expression using small RNA therapeutics and the improvement of precise gene editing now pave the way to applications such as
[142] Cardiovascular disease - Risk Factors, Prevention, Treatment | Britannica — Cardiovascular disease - Risk Factors, Prevention, Treatment: Three main risk factors have been identified: cigarette smoking, a high level of cholesterol in the blood (hypercholesterolemia), and high blood pressure (hypertension). Important as these risk factors are, they are found only in about one-half of those who experience heart attacks. The proportion of persons with any or all of these
[144] Heart Disease Risk Factors | Heart Disease | CDC - Centers for Disease ... — Heart Disease Risk Factors Several health conditions can increase your risk for heart disease. Several health conditions, your lifestyle, and your age and family history can increase your risk for heart disease. Key risk factors for heart disease include: High blood pressure is a major risk factor for heart disease. Obesity can lead to high blood pressure and diabetes as well as heart disease. Drinking too much alcohol can raise blood pressure levels and the risk for heart disease. Genetic factors likely play some role in high blood pressure, heart disease, and other related conditions. However, it is also likely that people with a family history of heart disease share common environments and other factors that may increase their risk.
[151] Effects of the Mediterranean Diet on Cardiovascular Outcomes—A ... — The Mediterranean diet was associated with a 37% relative reduction in the risk of major cardiovascular events (RR 0·63, 95% CI: 0·53-0·75, p< 0·001) compared to control diet. Exclusion of the study with serious concerns about its integrity (n = 1000, 145 events) did not result in a change of overall direction of the effect (RR 0.69, 95%
[153] DASH Dietary Pattern and Cardiometabolic Outcomes: An Umbrella Review ... — Conclusions: Current evidence allows for the conclusion that the DASH dietary pattern is associated with decreased incidence of cardiovascular disease and improves blood pressure with evidence of other cardiometabolic advantages in people with and without diabetes. More research is needed to improve the certainty of the estimates.
[154] How to implement a heart-healthy diet in daily life — Recent studies on diets for heart disease prevention. Adopting a heart-healthy diet is key to preventing heart disease. Including more fruits, vegetables and whole grains can lower cholesterol, reduce blood pressure and decrease the risk of heart disease. ... Understanding and applying the DASH diet. The DASH diet is an excellent guide for
[177] Genetics in Cardiovascular Disease - PMC — Known risks to its development are lifestyle choices, age, sex, and inherited genetic variants. An international research team (the CARDioGRAM and the Coronary Artery Disease Genetics Consortia) has confirmed ten previously identified markers associated with heart disease and uncovered 13 new genetic markers that increase heart disease risk.
[178] Human genetics and its impact on cardiovascular disease — We know there are several important genes (especially lipid-related genes) in which rare genetic variations are apparently associated with CVD risk, while a polygenic risk score comprising common genetic variations appears to work quite well among general populations.
[180] Understanding Your Risk for Heart Disease - UCSF Health — Non-modifiable risk factors for heart disease. Even though you can't change non-modifiable risk factors, it's important to be aware of them. Age. Age itself increases your risk of developing heart disease. According to the American Heart Association, about 80% of people who die from cardiovascular disease are 65 or older. Sex
[181] Modifiable & Non-Modifiable Risk Factors for Heart Disease — Modifiable & Non-Modifiable Risk Factors for Heart Disease – Amy Myers MD Non-Modifiable Risk Factors For Heart Disease Modifiable Risk Factors for Heart Disease While you cannot change your age, race, sex or family history, there are several modifiable risk factors of heart disease that are in your control. If you are diabetic, controlling your blood glucose levels will lower your risk of heart disease. Obesity and being overweight are linked to several modifiable risk factors of heart disease including high cholesterol, high blood pressure, and type 2 diabetes. By making lifestyle changes such as exercising more, changing your diet, losing weight, and relieving stress, you can lower your number of modifiable risk factors for heart disease.
[185] Emerging Therapeutic Strategies in Cardiovascular Diseases — Cardiovascular diseases (CVDs), including ischemic heart disease and stroke, are the leading cause of mortality worldwide, causing nearly 20 million deaths annually. Traditional therapies, while effective, have not curbed the rising prevalence of CVDs driven by aging populations and lifestyle factors. This review highlights innovative therapeutic strategies that show promise in improving
[196] The U.S. FDA approved cardiovascular drugs from 2011 to 2023: A ... — Cardiovascular disease (CVD) is the leading cause of morbidity and mortality worldwide. A total of 28 new molecular entities (NMEs) were approved by the U.S. Food and Drug Administration (FDA) for the treatment of cardiovascular diseases from 2011 to 2023. Approximately 25 % of the medications were sanctioned for the management of diverse vascular disorders. The other major therapeutic areas
[197] New pharmacological agents and novel cardiovascular pharmacotherapy ... — Cardiovascular diseases (CVD) remain the leading cause of death worldwide and pharmacotherapy of most of them is suboptimal. Thus, there is a clear unmet clinical need to develop new pharmacological strategies with greater efficacy and better safety profiles.
[198] FDA OKs Novel Treatment for Life-Threatening Heart Condition — The FDA has approved vutrisiran (brand name Amvuttra) as a new treatment for adults with a life-threatening heart condition called transthyretin amyloid cardiomyopathy (ATTR-CM).
[200] Emerging Therapeutic Strategies in Cardiovascular Diseases — Emerging therapies hold the promise of addressing unmet medical needs, improving patient outcomes, and potentially altering the course of CVDs. These innovative approaches include advanced pharmacological treatments, biological therapies, cutting-edge medical devices, and personalized medicine. The primary objective of this narrative review is to provide a comprehensive overview of the emerging therapeutic strategies in the treatment of CVDs. By examining the latest advancements in pharmacology, biological therapies, medical devices, and personalized medicine, this review aims to highlight the potential these innovations have in transforming cardiovascular care. Keywords included "cardiovascular diseases," "innovative therapies," "PCSK9 inhibitors," "SGLT2 inhibitors," "gene therapy," "stem cell therapy," "RNA-based treatments," "medical devices," "wearable technology," and "personalized medicine." Studies were selected based on their relevance to emerging CVD therapies, focusing on randomized controlled trials, observational studies, and meta-analyses.
[216] Personalized Cardiovascular Medicine Today | Circulation - AHA/ASA Journals — Personalized medicine, also referred to as individualized or precision medicine, is the practice of tailoring medical treatment to the individual characteristics of each patient. 1,2 The enormous potential of personalized medicine, to improve clinical outcomes by moving away from a one-size-fits-all approach and toward treatment strategies that are most likely to benefit each individual, has
[217] Personalized Medicine in Cardiovascular Diseases - PMC — There has been a flood of research aimed at genome-wide predisposition markers, pharmacogenetics, and genomic signatures in complex cardiovascular disorders.10) Research in the '-omic' sciences has resulted in improved understanding of the relationships between genes, proteins and disease, providing more tools for personalized medicine11-14) and driving a shift in medical practice.15) Currently, 10% of Food and drug Administration (FDA) of USA approved drugs include pharmacogenomic information on their labels16) and genetic testing is recommended or required for at least 11 FDA approved drugs.17) A number of applications of personalized medicine, based on genetic testing, are currently in use.18) Pharmacogenomics, the optimization of drug therapy based on genetic information, has been applied to improve clinical outcomes.
[232] Principal Care Management for Cardiology Care - HealthSnap, Inc. — Principal Care Management (PCM) represents a significant evolution in the management of chronic conditions, particularly within cardiology care. Focusing on patients with a single high-risk chronic condition, PCM offers specialized and intensive care management customized to individual patient needs. This approach is helpful in managing complex cardiovascular diseases such as hypertension
[234] The Effectiveness of Chronic Care Management for Heart Failure: Meta ... — To support decision making on how to best redesign chronic care by studying the heterogeneity in effectiveness across chronic care management evaluations for heart failure. ... and number of chronic care model components. Principal Findings. Our meta-analysis showed that chronic care management reduces mortality by a mean of 18 percent (95
[235] What is Principal Care Management? A 2024 Guide - Quadrant Health — Principal Care Management (PCM) specifically caters to patients who have a single, significant chronic condition that requires extensive management. The qualifying conditions for PCM are those expected to last at least three months and pose a substantial risk of hospitalization, deterioration in health, or functional decline.
[236] How to Improve Patient Engagement in Cardiology Clinics - LinkedIn — Improving patient engagement in cardiology clinics is a transformative process that enhances patient satisfaction, adherence to treatment plans, and overall health outcomes.
[237] Nurses' perceptions of factors influencing treatment engagement among ... — Patient motivation and support have been described as pivotal in engagement with treatment plans . Recent studies indicate that participation in cardiac rehabilitation is low. Nurses play a significant role in promoting engagement with treatment plans in inpatient and outpatient settings and in cardiac rehabilitation .
[238] Shared Decision Making in Cardiovascular Patient Care to Address ... — Shared decision making (SDM) is a collaborative process in which patients and providers work together to create mutually agreed‐on care plans. 1 SDM centers patients' values and preferences and can improve patient‐provider communication and patient experience. SDM is both grounded in and a natural extension of patient‐centered care and has the potential to advance health equity. 1, 2 We
[240] Patient Education in Chronic Disease Management — Patient education is a pivotal element in managing chronic diseases, empowering patients and caregivers with the knowledge, skills, and confidence necessary for effective health management. 34 In chronic heart failure, for example, effective self-management behaviors, such as regular monitoring of weight to detect fluid retention early
[246] Digital health technology in the prevention of heart failure and ... — Multiple randomized controlled trials have now demonstrated that various modes of noninvasive digital health technology, including teleconsultations, smartphone applications (apps), wearables, remote monitoring, and predictive analytics can influence patient behaviors in both the primary and secondary prevention of coronary artery disease and prevention and management of heart failure. HF is the most common hospital discharge diagnosis among older adults in the United States, and one-fifth of HF patients are readmitted within 30 days of discharge.11 It is estimated that by 2030, more than 8 million American adults will be living with HF, representing a 50% increase in its prevalence compared to 2012.12 Despite the availability of effective evidence-based treatment options, hospitalization rates are universally increasing13 and the prognosis of HF remains poor, with almost half of patients dying within 5 years of initial diagnosis.14 Noninvasive digital health technology, which encompasses teleconsultations, smartphone applications (apps), wearables, remote monitoring, and predictive analytics, holds promise to improve HF care and management.
[247] Telemedicine in Cardiology: Enhancing Access to Care and Improving ... — Additionally, telecardiology supports the remote diagnosis and management of acute cardiac events, such as myocardial infarctions, through real-time data transmission and collaboration between primary care providers and cardiologists , thereby further improving patient health outcomes. These regulatory and reimbursement challenges hinder telemedicine's widespread adoption and integration in cardiology despite its potential to significantly improve patient outcomes through enhanced monitoring, timely interventions, and better management of cardiovascular diseases. Although not well established at this time, the development of telemedicine protocols for emergency cardiology care, such as remote consultation during acute cardiac events, could potentially improve patient outcomes through early, more accessible care with experts providing a timely intervention in critical situations, hence improving the overall health outcome of cardiology emergencies.
[248] Advancing telemedicine in cardiology: A comprehensive review of ... — Today, telemedicine can effectively replace in person follow-up visits to produce comparable (but not necessarily superior) outcomes in cardiovascular disease management. A benefit of telemedicine is the potential reduction in follow-up time or time to intervention, which may lead to earlier detection and prevention of adverse events.
[252] Key Features for MedTech Patient Apps in 2025 — Personalized Care Plans. Veradigm FollowMyHealth focuses on creating tailored treatment plans that deliver results. For example, patients using the platform have seen a 20% boost in medication adherence. Telehealth Integration. The platform makes virtual care simple and accessible with a range of telehealth features:
[254] Telehealth in 2025: Revolutionizing Global Healthcare — This shift towards patient-centered care is expected to improve patient satisfaction and health outcomes. Conclusion. By 2025, telehealth and virtual care have become integral components of the healthcare ecosystem, transforming how care is delivered and experienced. The rise of telehealth has increased access to care, enhanced patient
[255] Telehealth in 2025: Transforming Healthcare Through Innovation and ... — Telehealth in 2025: Transforming Healthcare Through Innovation and Policy — CTeL.org Telehealth in 2025: Transforming Healthcare Through Innovation and Policy Telehealth is no longer a supplementary tool—it has become a cornerstone of healthcare delivery, driving improvements in patient outcomes, provider capabilities, and the economics of care. Recent analysis by the National Health Institute reveals that telehealth now accounts for 23% of all healthcare encounters nationwide, with some specialties reporting virtual visit rates exceeding 50%. Telehealth’s effectiveness varies across medical specialties, with some achieving remarkable returns on investment (ROI) and patient outcomes: Policy Frameworks Driving Telehealth Growth The Future of Telehealth: Innovation and Policy Priorities Telehealth has proven its value as a transformative force in healthcare, but its continued success relies on strategic investment, thoughtful implementation, and supportive policies.
[256] Digital health technologies in enhancing patient and caregiver ... — Digital health technologies in enhancing patient and caregiver engagement in heart failure management: Opportunities and challenges - ScienceDirect Digital health technologies in enhancing patient and caregiver engagement in heart failure management: Opportunities and challenges Integral to the landscape of digital health in heart failure management is the Information Technology Management (ITM) system, a comprehensive framework designed to optimize patient and caregiver engagement. The Information Technology Management (ITM) system represents a groundbreaking integration of digital tools and platforms designed to enhance the management of heart failure, aiming to transform patient care through innovation and technology. As we look towards the future of heart failure management, the convergence of digital health technologies and interventional cardiology stands at the forefront of innovative patient care.
[269] 5 trends in cardiology to watch - Harvard Health — Dr. Braunwald: The future of cardiology will focus on preventing heart disease very early in life, a concept known as primordial prevention. Instead of waiting until people develop risk factors such as high blood pressure, high cholesterol, or diabetes and treating them, we will be able to identify and prevent the development of those
[270] Precision Medicine and the future of Cardiovascular Diseases: A ... — The advent of precision medicine in cardiology has ignited new possibilities for individually personalized, integrative, and patient-centric approaches to disease prevention and treatment, incorporating the standard clinical data with advanced “omics”. Precision medicine in hypertension can specifically identify patient subgroups with distinct disease causation mechanisms and their differential responses to diverse antihypertensive treatments. The evolving approach of precision medicine advocates the individualization of therapy, directed by local regulations and guidelines based on novel markers and gene targets, which can help us define reasons for failure, thus evolving a better tailored patient-centric approach to curing diseases. 61.Kronish I.M., Cheung Y.K., Shimbo D., Julian J., Gallagher B., Parsons F., Davidson K.W. Increasing the Precision of Hypertension Treatment Through Personalized Trials: A Pilot Study.
[271] What might the next century hold for cardiovascular disease prevention ... — While no one can say for certain, experts point to three areas they expect may play a crucial role in the decades ahead: a push to halt the rise of cardiovascular risk factors using the knowledge gained in previous decades; the continued development of innovative technologies; and a heightened focus on the root causes of health disparities to prevent them from widening as the U.S. population grows more diverse. The American Heart Association compiled this knowledge into eight key measures that, if properly managed, could help to substantially lower the risk for heart disease, stroke and other major health problems. American Heart Association News covers heart disease, stroke and related health issues. *All health/medical information on this website has been reviewed and approved by the American Heart Association, based on scientific research and American Heart Association guidelines.
[279] What Are the RNA-Based Therapies in Cardiology? - iCliniq — What Are the Applications of RNA-Based Therapies in Cardiovascular Disease? 1. Genetic Cardiomyopathies: Gene alterations essential for heart function are frequently the source of genetic cardiomyopathies, including dilated cardiomyopathy (DCM) and hypertrophic cardiomyopathy (HCM). RNA-based treatments provide the opportunity to target these
[281] RNA Therapeutics for Cardiovascular Disease - PMC - PubMed Central (PMC) — Despite significant advances in treatment options, cardiovascular disease remains the number one cause of death in the United States and is responsible for 17.8 million deaths worldwide . While there are only a handful of clinical studies for RNA therapeutics for cardiovascular diseases, the increased research and investment in this area ensure
[283] Implementing Genome-Driven Personalized Cardiology in Clinical Practice ... — We are progressing toward a new personalized/precision cardiology where clinical multimodal data/traits, including genomic features, become part of a vast disease knowledge-network that can inform precise diagnoses and individualized treatments . In such a setting, a diagnosis itself will usually provide insight into a specific pathogenetic
[286] Genomic Medicine in Cardiology: Pioneering Precision Care for Heart Health — The future of genomic medicine in cardiology is promising, with ongoing research focused on. Refining risk prediction algorithms to improve clinical utility. Exploring the use of induced pluripotent stem cells (iPSCs) for regenerating damaged cardiac tissue. ... integrating metabolomic data with genomic profiles has shed light on the metabolic
[287] Wearable Biosensors in Pediatric Cardiovascular Disease: — In adult cardiovascular populations, there is already growing evidence of the benefit of mobile health technologies. However, most mobile health technologies, especially wearable biosensors, are not designed for children, despite numerous specific pathologies that could benefit from this technology.